Effect of Bacterial Extract, IRS-19, on the Concentration of Hydrogen Peroxide and Myeloperoxidase Activity in Nasal Washings of Patients with Chronic Bronchitis

Archivum Immunologiae et Therapiae Experimentalis

Volumn 45, Issue 1, 1997, Pages 67-72

  Nowak, Dariusz ^a   Prozyński, Michal ^b   Pietras, Tadeusz ^a   Stolarek, Robert ^a   Mazerant, Piotr ^a   Leder, Michal ^a  

^a University Medical School   (Poland)

^b NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

Author keywords

Bacterial extract; Chronic bronchitis; Hydrogen peroxide; IRS 19; Myeloperoxidase; Nasal washings; Polymorphonuclear leukocytes

Indexed keywords

BACTERIUM LYSATE; HYDROGEN PEROXIDASE; IMMUNOMODULATING AGENT; IRS 19; MYELOPEROXIDASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTERICIDAL ACTIVITY; CHRONIC BRONCHITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFENSE MECHANISM; DRUG EFFECT; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; NEUTROPHIL; NOSE CONGESTION;

ADJUVANTS, IMMUNOLOGIC; ADULT; BACTERIA; BRONCHITIS; CHRONIC DISEASE; FEMALE; HUMANS; HYDROGEN PEROXIDE; IMMUNITY, NATURAL; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NASAL LAVAGE FLUID; NEUTROPHILS; PEROXIDASE;

EID: 0030951902     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. ABDOU M. A., HANNA K. M., EL ATTAR S., ABDEL NABI E., HATEM A. and ABDEL GHAFFAR M. (1993): Influence of a bacterial extract, broncho-vaxom, on clinical and immunological parameters in patients with intrinsic asthma. Int. J. Immunotherapy, 9, 127-133.
2. ANDREWS P. C and KRINSKY N. (1982): A kinetic analysis of the interaction of human myeloperoxidase with hydrogen peroxide, chloride ions, and protons. J. Biol. Chem., 257, 13240-13245.
3. American Thoracic Society. Standardization of spirometry 1987 update. (1987): Am. Rev. Respir. Dis., 136, 1285-1298.
4. BABIOR B. M. (1984): Oxidants from phagocytes agents of defense and destruction. Blood, 64, 959-966.
5. BANDEKAR J. R., CASTAGNA R. and SULTZER B. M. (1992): Roles of protein kinase C and G proteins in activation of murine resting B lymphocytes by endotoxin-associated protein. Infect. Immun., 60, 231-236.
6. BORREGARD N., LOLLIKE K., KJELDSEN L., SENGELOV H., BASTHOLM L., NIELSEN M. H. and BAINTON D. F. (1993): Human neutrophil granules and secreetory vesicles. Eur. J. Heamatol., 51, 187-198.
7. BRADLEY P. P., CHRISTENSEN R. D. and ROTHSTEIN C. (1982): Cellular and extracellular myeloperoxidase in pyrogenic inflammation. Blood, 60, 618-622.
8. CANTIN A. M., FELLS G. A., HUBBARD R. C. and CRYSTAL R. G. (1990): Antioxidant macromolecules in the epithelial lining fluid of the normal human lower respiratory tract. J. Clin. Invest., 86, 962-971.
9. CLOT J. and ANDRY M. (1980): Immunostimulation induite par un lysat bacterien lyophilise. Etude in vitro des responses specifiques et non specifiques. Med. Hyg., 38, 2776-2782.
10. COHEN M. S., MAO J., RASMUSSEN G. T., SERODY J. S and BRITIGAN B. E. (1992): Interaction of lactoferrin and lipopolysaccharide (LPS): Effects on the antioxidant property of lactoferrin and the ability of LPS to prime human neutrophils for enhanced superoxide formation. J. Infect. Dis., 166, 1375-1378.
11. FOLLIN P. and DAHLGREN C. (1992): Phagocytosis by lipopolysaccharide primed human neutroophils is associated with increased extracellular release of reactive oxygen metabolites. Inflammation, 16, 83-91.
12. GOLDBLUM S. E., Wu K. M. and JAY M. (1985): Lung myeloperoxidase as a measure of pulmonary leukostasis in rabbits. J. Appl. Physiol., 59, 1978-1985.
13. HOMANN-MULLER J. W. T., WEENING R. S. and Ross D. (1975): Production of hydrogen peroxide by phagocytizing human granulocytes. J. Lab. Clin. Med., 85, 198-207.
14. MAUEL J., VAN PHAM T., KREIS B. and BAUER J. (1989): Stimulation by a bacterial extract (Broncho-Vaxom) of the metabolic and functional activities of murine macrophages. Int. J. Immunopharmacol., 11, 637-645.
15. MORGENROTH K. and NEWHOUSE M. T. (1983): Bronchitis. PVG, Pharmazeutische Verlagsgesellchaft mbH München, 80-88.
16. NOWAK D. (1990): Hydrogen peroxide release from human polymorphonuclear leukocytes measured with horseradish peroxidase and odianisidine. Effect of various stimulators and cytochalasin B. Biomed. Biochim. Acta, 49, 353-362.
17. NOWAK D., ANTCZAK A., KROL M., PIETRAS T., SHARIATI B., BIALASIEWICZ P., JECZKOWSKI K. and KULA P. (1996): Increased content by hydrogen peroxide in expired breath of cigarette smokers. Eur. Respir. J. 9, 652-657.
18. 2-halide system and stimuled polymorphonuclear leukocytes. Exp. Pathol., 42, 47-58.
19. NOWAK D., PIETRAS T., ANTCZAK A., KROL M. and PIASECKA G. (1993): Effect of bacterial lipopolysaccharide on the content of lipid peroxidation products in lungs and other organs of mice. Antonie Leeuwenhoek Int. J. Gen. M., 63, 77-83.
20. NOWAK D., RUTA U. and PIASECKA G. (1989): Ascorbic acid inhibits polymorphonuclear leukocytes influx to the place of inflammation - possible protection of lung from phagocyte-mediated injury. Arch. Immunol. Ther. Exp., 37, 213-218.
21. NOWAK D., RUTA U., PIASECKA G. (1990): Nicotine increases human polymorphonuclear leukocytes chemotactic response - a possible, additional mechanism of lung injury in cigarette smokers. Exp. Pathol., 39, 37-43.
22. NOWAK D., SŁODKOWSKA J., PIETRAS T., PIASECKA G., ANTCZAK A. and KROL M. (1993): Ascorbic acid enhances the decrease in peroxidase activity in inflammed tissues in mice. Arch. Immunol. Ther. Exp., 41, 321-326.
23. PIROZYŃSKI M., NOWAK D., PIROZYŃSKA E., KALCZAK M., NOWAK Z. and PIASECKA G. (1994): Zastosowanie donosowej aerozolowej immunoterapii w przewleklym zapaleniu oskrzeli. Poste(Combining ogonek)py Aerozoloterapii, 2, 117-123.
24. PUIGDOLLERS J. M., RODES SERNA G., HERNANDEZ DEL REY I., TILLO BARRUFFET M. T. and JOFRE TORROELLA J. (1980): Stimulation de la production d'immunoglobulines chez l'homme par l'administration orale d'un lysat bacterien. Respiration, 40, 141-149.
25. REPINE J. E., FOX R. B., BERGER E. M. and HARADA R. N. (1981): Effect of staphylococcal iron contnet on the killing of Staphylococcus aureus by polymorphonuclear leukocytes. Infect. Immun., 32, 407-410.
26. RICE W. G., KINKADE J. M. and PARMLEY R. T. (1986): High resolution of heterogeneity among human neutrophil granules.: physical, biochemmical, and ultrastructural properties of isolated fractions. Blood, 68, 541-555.
27. 2 production by macrophages and neutrophils with homovanillic acid and horse-radish peroxidase. J. Immunol. Methods, 63, 347-357.
28. VAN ZYL J. M., BASSOM K. and VAN DER VAL B. J. (1990): The oxyferrous adduct of myeloperoxidase (compound III) and its reactivity with chloride. S. Afr. J. Sci., 86, 199-203.
29. WELBOURN C. R. B., GOLDMAN G., PATERSON I. S., VALERI C. R., SHEPRO D. and HECHTAMN H. B. (1991): Neutrophil elastase and oxygen radicals: synergism in lung injury after hindlimb ischemia. Am. J. Physiol., 260, 1852-1856.
30. WINTERBOURN C. C. (1986): Myeloperoxidase as an effective inhibitor of hydroxyl radical production, implications for the oxidative reactions of neutrophils. J. Clin. Invest., 78, 545-550.
31. XINOGALOS S., DURATSOS D. and VARONOS D. (1993): Clinical effectiveness of broncho-vaxom (BV) in patients with chronic obstructive pulmonary disease. Int. J. Immunotherapy, 2, 135-142.